DX2S:F:F-Xtrackers - S&P ASX 200 UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 38.55

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

+19.06 (+3.52%)

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+1.51 (+2.95%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+1.65 (+2.95%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.45 (+2.92%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

-0.10 (-1.43%)

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

+4.62 (+4.86%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 45.80B
0ZC:F Zscaler Inc

+10.00 (+4.83%)

USD 37.92B
BSND:F Danone SA

-0.30 (-2.07%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+4.76 (+3.86%)

USD 24.77B

ETFs Containing DX2S:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.46% 31% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.46% 31% F 45% F
Trailing 12 Months  
Capital Gain -0.91% 27% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.91% 26% F 44% F
Trailing 5 Years  
Capital Gain 44.95% 47% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.95% 48% F 39% F
Average Annual (5 Year Horizon)  
Capital Gain 5.59% 54% F 56% F
Dividend Return 5.59% 51% F 48% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.97% 55% F 87% B+
Risk Adjusted Return 46.74% 50% F 63% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike